Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peritoneal Effusion”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Testing effectiveness (Phase 2)UnknownNCT03230708
What this trial is testing

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

Who this might be right for
Malignant Ascites
Hui ting Xu，MD 18
Not applicableLooking for participantsNCT07490626
What this trial is testing

At-Home Paracentesis for Cancer-Related Malignant Ascites (Paracentesis)

Who this might be right for
Malignant Ascites
University of Utah 20
Testing effectiveness (Phase 2)Ended earlyNCT02417753
What this trial is testing

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Who this might be right for
Ovarian CancerOvarian NeoplasmsAscites+2 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT01532427
What this trial is testing

ALFApump System Post Marketing Surveillance Registry

Who this might be right for
Liver CirrhosisRefractory AscitesMalignant Ascites
Sequana Medical N.V. 100
Very early researchLooking for participantsNCT04684459
What this trial is testing

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Who this might be right for
Peritoneal Carcinoma MetastaticPleural Effusion, MalignantHER2 Positive Malignancies
Sichuan University 18
Testing effectiveness (Phase 2)Ended earlyNCT02540356
What this trial is testing

Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

Who this might be right for
Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
Baxalta now part of Shire 2
Testing effectiveness (Phase 2)Looking for participantsNCT05438459
What this trial is testing

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

Who this might be right for
Gastric CancerPancreatic Cancer
Kyushu University 176
Early research (Phase 1)Looking for participantsNCT07007988
What this trial is testing

A Phase I Study of SIM0388 in Participants With Malignant Ascites.

Who this might be right for
Malignant Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd. 50
Testing effectiveness (Phase 2)WithdrawnNCT00908219
What this trial is testing

Bevacizumab to Prevent Malignant Ascites

Who this might be right for
Malignant Ascites
Baylor College of Medicine
Not applicableStudy completedNCT03200106
What this trial is testing

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

Who this might be right for
Malignant Ascites
Sequana Medical N.V. 17
Very early researchLooking for participantsNCT07561437
What this trial is testing

NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Base Therapeutics (Shanghai) Co., Ltd. 18
Large-scale testing (Phase 3)Study completedNCT00327444
What this trial is testing

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian NeoplasmsAscites
Sanofi 58
Testing effectiveness (Phase 2)Study completedNCT02122185
What this trial is testing

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Brenner TumorMalignant AscitesMalignant Pleural Effusion+25 more
University of Chicago 111
Large-scale testing (Phase 3)Study completedNCT00822809
What this trial is testing

CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers

Who this might be right for
CancerNeoplasmsCarcinoma+1 more
Neovii Biotech 230
Early research (Phase 1)UnknownNCT05303844
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fudan University 25
Large-scale testing (Phase 3)Study completedNCT00836654
What this trial is testing

Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group

Who this might be right for
EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)Malignant Ascites
Neovii Biotech 258
Testing effectiveness (Phase 2)Study completedNCT01065246
What this trial is testing

Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites

Who this might be right for
Malignant Ascites Due to Epithelial Carcinoma
Neovii Biotech 8
Early research (Phase 1)Looking for participantsNCT07658196
What this trial is testing

TLR9 Immunotherapy for Peritoneal Carcinomatosis

Who this might be right for
Malignant AscitesColorectal AdenocarcinomaPeritoneal (Metastatic) Cancer+1 more
Brown University 24
Not applicableUnknownNCT03550560
What this trial is testing

EUS-Guided Drainage of Refractory Malignant Ascites

Who this might be right for
Malignant Ascites
Hospital Universitario Virgen Macarena 100
Not applicableEnded earlyNCT03189108
What this trial is testing

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer+1 more
National Cancer Institute (NCI) 22
Next Page